Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The possibility that hypersecretion of corticotropin-releasing factor (CRF) contributes to the hyperactivity of the hypothalamo-pituitary-adrenal axis observed in patients with major depression was investigated by measuring the concentration of this peptide in cerebrospinal fluid of normal healthy volunteers and in drug-free patients with DSM-III diagnoses of major depression, schizophrenia, or dementia. When compared to the controls and the other diagnostic groups, the patients with major depression showed significantly increased cerebrospinal fluid concentrations of CRF-like immunoreactivity; in 11 of the 23 depressed patients this immunoreactivity was greater than the highest value in the normal controls. These findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA alterations correlate with impaired cognitive function 66,67 in depressed patients”
From Major depressive disorder (2016) · cites this paper as [67]
In the citing paper
“elevated basal cerebrospinal fluid CRH levels”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Nemeroff et al., 1984
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citationCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Corticotropin-Releasing Factor: Actions on the Sympathetic Nervous System and Metabolism*
BROWN, M. R., FISHER, L. A., SPIESS, J., RIVIER, C., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-111-3-928 · Cited by 651
Self-citationNeuroendocrine Regulation in Depression: II. Discrimination of Depressed From Nondepressed Patients
Carroll, B. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090041003 · Cited by 627
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 481
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus
Bloom, F. E., Battenberg, E. L. F., Rivier, J., & Vale, W. (1982) · Regulatory Peptides · doi:10.1016/0167-0115(82)90107-0 · Cited by 364
Self-citationGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Research works printed but not linked: 6
- Carroll, B. J., Handbook on Depression: 325 (1977).
- FISHMAN, A.J., PEPTIDES 1: 149 (1982).
- Rivier, J., Proceedings of the National Academy of Sciences of the United States of America 80: 4851 (1983).
- SNEDECOR, G.W., STAT METHODS: 271 (1967).
- SOKAL, R.R., BIOMETRY: 391 (1969).
- WHYBROW, P.C., MOOD DISORDERS NEW P: 1 (1984).
Cited by
Items 101–200 of 1,001
Etiology of Depression: Genetic and Environmental Factors
Saveanu, R. V., & Nemeroff, C. B. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.12.001 · Cited by 356
Self-citationHeim, C., Mletzko, T., Purselle, D., Musselman, D. L., & Nemeroff, C. B. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.002 · Cited by 353
Self-citationRisk and resilience: genetic and environmental influences on development of the stress response
Gillespie, C. F., Phifer, J., Bradley, B., & Ressler, K. J. (2009) · Depression and Anxiety · doi:10.1002/da.20605 · Cited by 351
“g.([15,16])), as well as in combat veterans with PTSD.”
BackgroundBauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 346
Reul, J. M. (1993) · Endocrinology · doi:10.1210/en.133.1.312 · Cited by 345
Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341
Birth weight and the risk of depressive disorder in late life
Thompson, C., Syddall, H., Rodin, I., Osmond, C., & Barker, D. J. P. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.5.450 · Cited by 341
De Souza, E. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-01-00088.1987 · Cited by 338
“Nemeroff, C. B., E. Widerlov, G. Bissette, H. Walleus, I. Karlsson, K. Eklund, C. D. Kilts, P. T. Loosen, and W. Vale (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.”
BackgroundBrady, L. S., Whitfield, H. J., Fox, R. J., Gold, P. W., & Herkenham, M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115086 · Cited by 337
ANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
“Consistent with the view that CRH may be related to depression, CRH concentrations in cerebrospinal fluid (CSF) were elevated among depressed patients (Arato et al., 1989; Arborelius et al., 1999; Arranz et al., 1992; Heuser et al., 1998; Nemeroff et al., 1984; Wong et al., 2000), which normalized with pharmacotherapy…”
CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.7.873 · Cited by 336
Self-citationEstrogen, Stress, and Depression: Cognitive and Biological Interactions
Albert, K. M., & Newhouse, P. A. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095557 · Cited by 334
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
Wichers, M., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003103 · Cited by 329
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 329
“, 2011), which is characteristic for a subset of depressed patients (Nemeroff et al., 1984).”
InfluentialHayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324
Corticotropin-releasing factor and neuropeptide y: role in emotional integration
Heilig, M., Koob, G. F., Ekman, R., & Britton, K. T. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90079-5 · Cited by 324
The neuroendocrinology of depression and chronic stress
Checkley, S. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011570 · Cited by 322
LINKOWSKI, P., MENDLEWICZ, J., KERKHOFS, M., LECLERCQ, R., GOLSTEIN, J., BRASSEUR, M., COPINSCHI, G., & CAUTER, E. V. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-1-141 · Cited by 320
Neurotransmitter Switching in the Adult Brain Regulates Behavior
Dulcis, D., Jamshidi, P., Leutgeb, S., & Spitzer, N. C. (2013) · Science · doi:10.1126/science.1234152 · Cited by 317
Trauma and substance abuse: Causes, consequences, and treatment of comorbid disorders.
(2003) · American Psychological Association eBooks · doi:10.1037/10460-000 · Cited by 310
Koehl, M., Darnaud�ry, M., Dulluc, J., Van Reeth, O., Moal, M. L., & Maccari, S. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19990905)40:3<302::aid-neu3>3.0.co;2-7 · Cited by 303
The neurodevelopmental origins of suicidal behavior
Turecki, G., Ernst, C., Jollant, F., Labonté, B., & Mechawar, N. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.008 · Cited by 299
Konarski, J. Z., McIntyre, R. S., Kennedy, S. H., Rafi‐Tari, S., Soczynska, J. K., & Ketter, T. A. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00435.x · Cited by 299
“Discussion Neuropathophysiology of stress An increase in circulating cortisol levels during depressed or mixed episodes has been one of the most robust findings in mood disorders (250, 251).”
ResultGold, P. W., & Chrousos, G. P. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.09423.x · Cited by 298
Loss of Glucocorticoid Fast Feedback in Depression
Young, E. A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320017003 · Cited by 298
A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze
Mechiel Korte, S., & De Boer, S. F. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01279-2 · Cited by 297
“There are several studies supporting the hypothesis that hypersecretion of CRF is a crucial factor in anxiety disorders and depression (Nemeroff et al., 1984).”
BackgroundWong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
Interplay between the gut-brain axis, obesity and cognitive function
Agustí, A., García-Pardo, M. P., López-Almela, I., Campillo, I., Maes, M., Romaní-Pérez, M., & Sanz, Y. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00155 · Cited by 294
“This is supported by different studies demonstrating that activation of the stress response via the HPA-axis leads to the secretion of glucocorticoids (GCs), which in turn modulate immunity (Baschant and Tuckermann, 2010; Zen et al., 2011), as well as by studies showing that mood disorders are commonly associated with…”
BackgroundInfluentialAltered colonic function and microbiota profile in a mouse model of chronic depression
Park, A. J., Collins, J., Blennerhassett, P. A., Ghia, J. E., Verdu, E. F., Bercik, P., & Collins, S. M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12153 · Cited by 293
VALENTINO, R. J., FOOTE, S. L., & PAGE, M. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb49931.x · Cited by 292
Heimer, L., Harlan, R. E., Alheid, G. F., Garcia, M. M., & de Olmos, J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00405-8 · Cited by 288
Wolf, O. T., & Kirschbaum, C. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00021-1 · Cited by 287
Adrenal Gland Enlargement in Major Depression: A Computed Tomographic Study
Nemeroff, C. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820050048008 · Cited by 283
Self-citationThe molecular bases of the suicidal brain
Turecki, G. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3839 · Cited by 281
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.93 · Cited by 275
“This concept is supported by studies showing high CRH levels in CSF and a lower than normal number of central CRH receptors among depressed patients (3, 4).”
ResultPersonalized medicine in psychiatry: problems and promises
Ozomaro, U., Wahlestedt, C., & Nemeroff, C. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-132 · Cited by 270
“spinal fluid (CSF) are a consistently replicated finding in patients with depression, and is also seen in suicide victims [28-31], rendering CRHR1 an attractive candidate gene for MDD susceptibility.”
BackgroundSelf-citationBornstein, S. R., Schuppenies, A., Wong, M.-L., & Licinio, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001873 · Cited by 266
Parental Depression: Animal Models of an Adverse Life Event
Newport, D. J., Stowe, Z. N., & Nemeroff, C. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1265 · Cited by 266
Self-citationBiological mechanisms in the relationship between depression and heart disease
Grippo, A. J., & Johnson, A. K. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00003-4 · Cited by 265
“[183] Nemeroff CB, Widerlöv E, Bissette G, Walléus H, Karlsson I,”
BackgroundWiderlöv, E., Lindström, L. H., Wahlestedt, C., & Ekman, R. (1988) · Journal of Psychiatric Research · doi:10.1016/0022-3956(88)90030-1 · Cited by 263
Self-citationNew insights into the role of perinatal HPA-axis dysregulation in postpartum depression
Glynn, L. M., Davis, E. P., & Sandman, C. A. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.007 · Cited by 262
“For example, those suffering from MDD exhibit elevated concentrations of CRH in cerebrospinal fluid and these levels are reduced following ECT therapy (Kasckow et al., 2001; Nemeroff et al., 1984).”
BackgroundMakino, S., Hashimoto, K., & Gold, P. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00791-8 · Cited by 260
The Corticotropin-Releasing Factor Family: Physiology of the Stress Response
Deussing, J. M., & Chen, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2017 · Cited by 260
Role of kappa-opioid receptors in stress and anxiety-related behavior
Van’t Veer, A., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 257
“In humans, major depressive disorder has been associated with higher levels of cerebrospinal fluid CRF (Arato et al. 1989; Kasckow et al. 2001; Nemeroff et al. 1984; Widerlov et al. 1988), and CRF levels are also elevated in patients with PTSD (Baker et al. 1999; Bremner et al. 1997; de Kloet et…”
Bradley, A. J., & Dinan, T. G. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385491 · Cited by 256
“Basal CRH in CSF was measured in five of these studies (Banki et al., 1987, 1992; Nemeroff et al., 1984; Nishino et al., 1998; Risch et al., 1992).”
MethodNemeroff, C. B., Bissette, G., Akil, H., & Fink, M. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.158.1.59 · Cited by 254
Self-citationMakino, S., Gold, P. W., & Schulkin, J. (1994) · Brain Research · doi:10.1016/0006-8993(94)90961-x · Cited by 249
Region-specific roles of the corticotropin-releasing factor–urocortin system in stress
Henckens, M. J. A. G., Deussing, J. M., & Chen, A. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.94 · Cited by 247
Sensitization of the Hypothalamic‐Pituitary‐Adrenal Axis in Posttraumatic Stress Disordera
YEHUDA, R. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48269.x · Cited by 247
Psychoneuroendocrinological links between chronic stress and depression
Tafet, G. E., & Bernardini, R. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00162-3 · Cited by 246
“, 1986), as well as an increased release of CRH (Nemeroff et al., 1984; Roy et al., 1987), but normal levels of ACTH (Fang et al.”
BackgroundHypothalamic-pituitary-adrenal axis and bipolar disorder
Daban, C., Vieta, E., Mackin, P., & Young, A. H. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.01.005 · Cited by 245
Stress sensitivity and the development of affective disorders
Bale, T. L. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.033 · Cited by 245
“Further, excessive activation of the HPA axis has been reported in over half of patients with depression, and these symptoms have been ameliorated following a course of antidepressant treatment (Arato et al., 1989; Banki et al., 1987; De Bellis et al., 1993; Nemeroff et al., 1984).”
BackgroundPearson Murphy, B. E. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90312-s · Cited by 244
Long-term effects of childhood abuse on brain and neurobiology
Bremner, J. D. (2003) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(02)00098-6 · Cited by 243
Adrenocortical function, social rank, and personality among wild baboons
Sapolsky, R. M. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90568-m · Cited by 242
Schulz, A. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.00993 · Cited by 240
“On the other hand, the more frequent melancholic sub-type is characterized by hypersecretion of CRF (Nemeroff et al., 1984; Wong et al., 2000), and reduced concentration and sensitivity of CRF neurons, resulting in a blunted ACTH response to CRF administration (Gold et al., 1988; Lesch et al., 1988; Ehlert et al., 200…”
BackgroundInfluentialThe Neurobiological Toll of Child Abuse and Neglect
Neigh, G. N., Gillespie, C. F., & Nemeroff, C. B. (2009) · Trauma, Violence, & Abuse · doi:10.1177/1524838009339758 · Cited by 240
“, 1997) as well as depressed patients (Nemeroff et al., 1984; Wong et al., 2000), and increased numbers of CRF immunoreactive neurons and CRF messenger RNA (mRNA) expression have been observed in the postmortem tissue of depressed patients (Purba et al.”
BackgroundSelf-citationHOTTA, M., SHIBASAKI, T., MASUDA, A., IMAKI, T., DEMURA, H., LING, N., & SHIZUMe, K. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-2-319 · Cited by 239
Varghese, F. P., & Brown, E. S. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0401 · Cited by 236
Role of corticotropin releasing factor in anxiety disorders: A translational research perspective
Risbrough, V. B., & Stein, M. B. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.019 · Cited by 236
“Concentrations of CRF in cerebrospinal fluid (CSF) appear to be higher in depressed patients (Nemeroff, 1998;Nemeroff et al., 1984) and can be reduced with electroconvulsive shock treatment (Nemeroff et al., 1991).”
BackgroundThe influence of stress hormones on emotional memory: Relevance for psychopathology
Wolf, O. T. (2008) · Acta Psychologica · doi:10.1016/j.actpsy.2007.08.002 · Cited by 235
Brady, L. S., Gold, P. W., Herkenham, M., Lynn, A. B., & Whitfield, H. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)90459-m · Cited by 235
KRISHNAN, K. R. R., DORAISWAMY, P. M., LURIE, S. N., FIGIEL, G. S., HUSAIN, M. M., BOYKO, O. B., ELLINWOOD, E. H., & NEMEROFF, C. B. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-256 · Cited by 232
Self-citationThe role of the gut microbiota in dietary interventions for depression and anxiety
Bear, T. L. K., Dalziel, J. E., Coad, J., Roy, N. C., Butts, C. A., & Gopal, P. K. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa016 · Cited by 229
Contarino, A., Dellu, F., Koob, G. F., Smith, G. W., Lee, K.-F., Vale, W., & Gold, L. H. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01158-5 · Cited by 228
Self-citationThe brain mineralocorticoid receptor: greedy for ligand, mysterious in function
Reul, J. M. H. M., Gesing, A., Droste, S., Stec, I. S. M., Weber, A., Bachmann, C., Bilang-Bleuel, A., Holsboer, F., & Linthorst, A. C. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00677-4 · Cited by 227
Effects of Corticotropin-Releasing Factor on Brain Serotonergic Activity
Price, B. A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00197-8 · Cited by 226
“Taken with evidence for CRF hypersecretion in depression (Banki et al. 1987; Gold et al. 1984; Nemeroff et al. 1984, 1988; Roy et al. 1987) and release of CRF during acute drug withdrawal states (Menzaghi et al. 1994; Sarnyai et al. 1995), these findings lead to the intriguing hypothesis that…”
Stress, depression and Parkinson's disease
Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.035 · Cited by 225
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript mRNA expression and cell number in the hypothalamus as well as increased levels of CRH in cerebrospinal fluid (Nemeroff et al., 1984; Swaab et al., 2005).”
BackgroundFrom monoamines to genomic targets: a paradigm shift for drug discovery in depression
Wong, M.-L., & Licinio, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1303 · Cited by 225
Novel Drugs and Therapeutic Targets for Severe Mood Disorders
Mathew, S. J., Manji, H. K., & Charney, D. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301652 · Cited by 223
Bertagna, X., Guignat, L., Groussin, L., & Bertherat, J. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.001 · Cited by 222
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
Mazza, M. G., Palladini, M., Poletti, S., & Benedetti, F. (2022) · CNS Drugs · doi:10.1007/s40263-022-00931-3 · Cited by 220
Goldston, K., & Baillie, A. J. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.05.005 · Cited by 216
Cardiovascular alterations and autonomic imbalance in an experimental model of depression
Grippo, A. J., Moffitt, J. A., & Johnson, A. K. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00614.2001 · Cited by 216
“, cortisol, adrenocorticotrophic hormone) in response to stressors and orthostatic challenges, suggesting a hyperreactive physiological stress response (2,24).”
BackgroundMarais, L., van Rensburg, S. J., van Zyl, J. M., Stein, D. J., & Daniels, W. M. U. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.01.011 · Cited by 215
“One of the characteristic biochemical features of these disorders is the presence of a dysregulated hypothalamic-pituitary-adrenal (HPA) -axis as evidenced by a hypersecretion of corticotropin-releasing factor (CRF) (Nemeroff et al., 1984), as well as abnormalities in the basal secretion of adrenocorticotropin hormone…”
BackgroundInfluentialPharmacological Treatment of Anxiety Disorders: The Role of the HPA Axis
Tafet, G. E., & Nemeroff, C. B. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00443 · Cited by 214
Self-citationGesing, A., Bilang-Bleuel, A., Droste, S. K., Linthorst, A. C. E., Holsboer, F., & Reul, J. M. H. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04822.2001 · Cited by 210
“Depressed patients show elevated cerebrospinal fluid levels of CRH (Nemeroff et al., 1984), increased numbers of CRH and CRH/vasopressin-expressing neurons in their paraventricular nucleus (PVN) (Raadsheer et al.”
BackgroundCarpenter, L. L., Tyrka, A. R., McDougle, C. J., Malison, R. T., Owens, M. J., Nemeroff, C. B., & Price, L. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300375 · Cited by 209
“…(2004) 29, 777–784 & 2004 Nature Publishing Group All rights reserved 0893-133X/04 $25.00 www.neuropsychopharmacology.org et al, 1988; Nemeroff et al, 1984; Widerlov et al, 1988), although discrepant reports have appeared (Geracioti et al, 1997, 1992; Kling et al, 1991; Pitts et…”
BackgroundInfluentialSelf-citationLarson, S. L., Owens, P. L., Ford, D., & Eaton, W. (2001) · Stroke · doi:10.1161/hs0901.094623 · Cited by 208
Roy, A. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330081010 · Cited by 208
Ross, J. A., & Van Bockstaele, E. J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.601519 · Cited by 207
Yehuda, R., Halligan, S. L., Golier, J. A., Grossman, R., & Bierer, L. M. (2004) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00052-0 · Cited by 206
Handa, R. J., Pak, T. R., Kudwa, A. E., Lund, T. D., & Hinds, L. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.09.012 · Cited by 205
“Depressed patients have increased ACTH and cortisol secretory responses (Rubin et al, 1987) and elevated cortisol and CRH in CSF (Nemeroff et al. 1984).”
BackgroundElevated CSF CRF in suicide victims
Arató, M., Bánki, C. M., Bissette, G., & Nemeroff, C. B. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90183-2 · Cited by 205
Self-citationNovati, A., Roman, V., Cetin, T., Hagewoud, R., den Boer, J. A., Luiten, P. G. M., & Meerlo, P. (2008) · SLEEP · doi:10.1093/sleep/31.11.1579 · Cited by 204
Corticotropin-releasing hormone in depression and post-traumatic stress disorder
Kasckow, J. W., Baker, D., & Geracioti, T. D. (2001) · Peptides · doi:10.1016/s0196-9781(01)00399-0 · Cited by 204
Behavioral and cardiovascular changes in the chronic mild stress model of depression
Grippo, A. J., Beltz, T. G., & Johnson, A. K. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00050-7 · Cited by 203
Serotonin type-1A receptor imaging in depression
Drevets, W. C., Frank, E., Price, J. C., Kupfer, D. J., Greer, P. J., & Mathis, C. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00119-0 · Cited by 203
Tsigos, C., & Chrousos, G. P. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30078-1 · Cited by 201
Kunugi, H., Hori, H., Adachi, N., & Numakawa, T. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02135.x · Cited by 200
GOLD, P. W., LICINIO, J., WONG, M., & CHROUSOS, G. P. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44723.x · Cited by 199
Keck, M. E., & Holsboer, F. (2001) · Peptides · doi:10.1016/s0196-9781(01)00398-9 · Cited by 198
HEIM, C., OWENS, M. J., PLOTSKY, P. M., & NEMEROFF, C. B. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48279.x · Cited by 197
Self-citationGrippo, A. J., Cushing, B. S., & Carter, C. S. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31802f054b · Cited by 196
“The ANOVA yielded a significant main effect (F(1,18) 12.”
BackgroundMethodAntidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist
Mansbach, R. S., Brooks, E. N., & Chen, Y. L. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00025-3 · Cited by 195
Bremner, J. D., Vythilingam, M., Vermetten, E., Vaccarino, V., & Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.637 · Cited by 192
Wood, S. K., & Bhatnagar, S. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.11.002 · Cited by 192
Hill, M. N., & Gorzalka, B. B. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00006 · Cited by 192
“First, CRH immunoreactivity is upregulated in the CSF of depressed patients (Nemeroff et al., 1984; Widerlov et al., 1988) as well as in the locus coeruleus (Bissette et al., 2003) and peripherally in the plasma (Catalan et al., 1998), suggesting hypersecretion.”
BackgroundCrosstalk between the microbiota-gut-brain axis and depression
Du, Y., Gao, X.-R., Peng, L., & Ge, J.-F. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04097 · Cited by 191
“Indeed, depression is often accompanied by overactivation of the HPA axis, and increased concentrations of CRH in the cerebrospinal fluid could allow access to intestinal epithelial cells [96], leading to increased gut permeability.”
BackgroundAltered Structure of Dynamic Electroencephalogram Oscillatory Pattern in Major Depression
Fingelkurts, A. A., & Fingelkurts, A. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.011 · Cited by 190
Metadata
- Authors
- Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W.
- Affiliations
- Duke University (US)
- Uppsala University (SE)
- Duke Medical Center (US)
- University of Gothenburg (SE)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1984-12-14
- Volume
- 226
- Issue
- 4680
- Pages
- 1342-1344
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1974253960
- Semantic Scholar
- 1a0f9dda77d66396db9247777d53158b0628b325
- Cited by
- 1,485
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 34 · 2016: 36 · 2015: 34 · 2014: 46 · 2013: 39 · 2012: 37
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, cerebrospinal fluid, major depressive disorder, hypothalamic-pituitary-adrenal axis, hypersecretion, schizophrenia, dementia
- MeSH terms
- Adult, Aged, Corticotropin-Releasing Hormone, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Radioimmunoassay, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.